Activity of Anlotinib in the Second-Line Therapy of Metastatic Gastrointestinal Stromal Tumors: A Prospective, Multicenter, In Vitro Study.

Yongjian Zhou, Chunling Zeng,Xiaofeng Sun,Jun Zhang,Hongyan Qu,Xinhua Zhang,Ye Zhou,Zimin Liu,Xiaojun Wu,Xin Wu,Xuelong Jiao,Lin Shen,Yanbing Zhou,Yuexiang Wang,Jian Li

The oncologist（2023）

引用 0|浏览34

暂无评分

摘要

Anlotinib showed moderate antitumor activity in drug-resistant GIST cell lines in vitro, and good PFS and better tolerance in second-line therapy study.

查看译文

关键词

anlotinib,antitumor activity,gastrointestinal stromal tumor,second-line treatment

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要